Resources

Resources

Explore our resources developed for HCPs, patient advocacy groups, patients, caregivers, and friends & family of people living with advanced breast cancer
Guidelines
Brain Metastases
Honestly Spoken
Hard-to-Reach Toolkit
Patient Biomarker Survey
Peer Navigation Program
Lancet Commission
Additional Resources

GUIDELINES

The ABC guidelines are based on the most up-to-date evidence and can be used and adapted to guide treatment decisions in many different healthcare settings globally. They are updated at each biennial Advanced Breast Cancer International Consensus Conference, which has established itself as a major international breast cancer conference with the primary aim of developing international consensus guidelines for the management of ABC.

The ABC Consensus Conference's primary goal is the development of international consensus guidelines for the management of advanced breast cancer patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision-making in many different healthcare settings globally, with the necessary adaptations due to different access to care. Throughout the years, these guidelines have been endorsed by several international and European oncology organisations, such as EUSOMA (European Society of Breast Cancer Specialists), ESTRO (European Society of Radiation Oncology), ESGO (European Society of Gynaecological Oncology), UICC (Union International Contre le Cancer), SIS (Senologic International Society), ISS (International School of Senology), FLAM (Federación Latino-Americana de Mastología), OECI (Organisation of European Cancer Institutes), Susan G. Komen and BCRF (Breast Cancer Research Foundation), and have official representation from ASCO. Several organisations around the world have been adapting these guidelines to their country specific environment, particularly in terms of accessibility.

ABC6 & 7 GUIDELINES

ABC5 GUIDELINES

ABC4 GUIDELINES

ABC1 GUIDELINES

INTERNATIONAL GUIDELINES FOR MANAGEMENT OF METASTATICBREAST CANCER: CAN METASTATIC BREAST CANCER BE CURED?

INTERNATIONAL GUIDELINES FOR MANAGEMENT
OF METASTATIC BREAST CANCER: COMBINATION VS SEQUENTIAL SINGLE-AGENT CHEMOTHERAPY

Metastatic breast cancer. Recommendations proposal from the European School of Oncology

Brain metastases in breast cancer

Considering that nearly one in three individuals with metastatic breast cancer may face brain metastases, our collaboration with Seagen has led to the creation of an informative video about brain metastases. This resource offers valuable insights into how these metastases develop, how to recognize them, and when it's essential to seek guidance from your healthcare providers.

Explore

honestly spoken

The ABC Global Alliance has partnered with Sanofi to raise awareness of the burden and unmet needs of people living with metastatic breast cancer (MBC) through powerful storytelling, tangible advice and real-world examples. Honestly Spoken focusses on giving voice to the issues that matter most to MBC patients and caregivers through real, unscripted conversations led by patients, caregivers, healthcare professionals and experts from around the world. No topic, issue or personal experience is off limits as we seek to focus on the unique needs and priorities for the MBC Community. Join the conversation and watch the latest Honestly Spoken discussions.

Topics of the videos

• NAVIGATING CLINICAL TRIALS
• DEMYSTIFYING TERMINOLOGY
• CARING FOR OUR CAREGIVERS
• MAXIMIZING COMMUNICATION WITH YOUR DOCTOR
• PARENTING WITH MBC
• SUPPORTIVE AND PALLIATIVE CARE

Watch the whole series here

hard-to-reach abc/mbc communities toolkit

To address the critical unmet need in access to care for hard-to-reach populations with advanced/ metastatic breast cancer (ABC/MBC), the ABC Global Alliance and Pfizer have collaborated to develop a toolkit of relevant, community-based initiatives and best practice summary documents that aims to drive collaboration across the global ABC/MBC community.

View the Toolkit

Global ABC/MBC patient biomarker survey whitepaper

People with advanced/metastatic breast cancer (ABC/MBC) require an understanding of the biomarkers relevant to their diagnosis to actively engage in shared decision-making with their healthcare team. It may also help to alleviate some of the uncertainty that comes with a diagnosis and improve patient-reported outcomes.  

ABC Global Alliance partnered with AstraZeneca to develop a global survey of people with ABC/MBC, investigating their understanding and recall of related biomarkers, and their experiences and challenges in learning about the type of breast cancer they have. The survey culminated in the development of a whitepaper outlining key challenges and opportunities for change to empower patients with the knowledge and information to take an active role in their own care.

View the Whitepaper

*This study and the accompanying whitepaper were developed and funded by AstraZeneca, in partnership with ABC Global Alliance. Z4-65060. Date of Preparation: May 2024.

Advanced Breast Cancer Peer Navigation Program

A Navigator proactively collaborates with a patient and provides guidance with the complex issues of health, services and potential barriers throughout the cancer experience.

Learn More

The Lancet Breast Cancer Commission

Over the past two years, the international multidisciplinary group of experts, including our President, Dr Fatima Cardoso, has worked to transform the breast cancer care landscape. The Lancet Commission on Breast Cancer, launched in April 2024, released findings and recommendations on improving breast cancer care globally has led debate around key issues, supported pilot studies, culminating it its landmark report to help reduce the impact of breast cancer on society.

Recent progress in research and treatment has helped reduce the number of deaths from breast cancer, with decreases of up to 40% in some high-income countries. However, breast cancer still poses an enormous burden worldwide, with the Commission stating, “society, governments and decision-makers in the health sector only see the tip of an iceberg.”

Inequities in healthcare, along with the hidden costs of breast cancer, mean that many women and some men are being left behind and forgotten. This is a global problem, with the Commission highlighting key barriers that prevent progress in its report advocating for six crucial areas for change.

Additional Resources

Advanced Breast Cancer Guidelines in Latin America: Assessment, Adaptation, and Implementation of Fifth Advanced Breast Cancer Consensus Guidelines

View

Major global study reveals worldwide variations in the stage at which women are diagnosed with breast cancer: disparities found in stage at breast cancer diagnosis

View

VIDEO By SHORE-C: They just don't know what to say or do

View

Global Breast Cancer Initiative Implementation Framework: Assessing, strengthening and scaling up services for the early detection and management of breast cancer

View

Challenges in optimizing care in advanced breast cancer patients: Results of an international survey linked to the ABC1 consensus conference

View

Here and Now Survey Results

View

Metastatic breast cancer patients: The forgotten heroes!

View

The Count Us, Know Us, Join Us and Here & Now surveys

View